Portfolio news - Exscientia raises US$26 million in Series B funding round and announces AI drug discovery collaboration with Roche worth up to CHF 67 million
The Company has raised US$26 million in a Series B financing round to scale up its pipeline and advance selected programmes towards clinical development.